Home > Blog Tag

Blog Posts by Tag: Pathology

United Healthcare Reimbursement Policy Update for Molecular Pathology

United Healthcare announced that the effective date of their reimbursement policy update for molecular pathology has moved from dates of service beginning September 1, 2019, to dates of service beginning November 1, 2019.This reimbursement policy change affects claims submitted with codes for Tier 1 and Tier 2 Molecular Pathology. Tier 2 Molecular Pathology codes are 81400 – 81408, and are to be...

Read


Laboratory Economics' Anatomic Pathology & Clinical Lab Survey

Attention pathology groups! Laboratory Economics, an independent market research firm focused on the business of pathology and laboratory medicine, is conducting a survey to gain insight on current business trends among anatomic pathology groups and clinical labs. Please take a few moments to fill out this survey and in return for your participation, you will receive a full summary of the survey...

Read


Digital Pathology Primary Diagnosis is Approved – Is Your Lab Ready for the Future?

Earlier this month, there was an exciting announcement that Leica received their FDA 510(k) clearance to market a digital pathology whole slide imaging system for primary diagnosis. This comes on the heels of Philips’ groundbreaking announcement of FDA clearance in late 2017, which was the first device ever cleared for primary diagnosis. These advancements are initiating significant momentum in...

Read


Hidden Landmines in Revenue Cycle Management: 4 Rules of Report Analysis to Follow (Part 3)

This is the third post of a three-part blog series focused on key areas of business performance management for pathology practices, hospital outreach programs, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here: Part 1 and Part 2 At the recent Executive War College, I had the honor of...

Read


Hidden Landmines in Revenue Cycle Management: Misleading Metrics (Part 2)

This is the second post of a three-part blog series focused on key areas of business performance management for pathology practices, hospital outreach programs, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here: Part 1 and Part 3 Below, we have detailed the need for a complete understanding of...

Read


Hidden Landmines in Revenue Cycle Management: Industry Challenges, Patient Engagement, and Denial Trends (Part 1)

This is the first post of a three-part blog series focused on key areas of business performance management for pathology practices, hospital outreach programs, diagnostic laboratories, and molecular diagnostic providers. The other blog posts in this series can be found here:  Part 2 and Part 3 A number of trends in payor behaviors and...

Read


Hidden Landmines in RCM: Understanding Trends that Impact Financial Performance of Laboratories and Pathology Practices

With layers of complexity in revenue cycle management, it’s pertinent laboratories and pathology practices understand the challenges that may unknowingly be impacting revenue. Industry trends consistently change how we approach the nuances of the RCM process. How trends in top denials shifted in the last several year's impacts how we edit on the front-end and appeal on the back-end. Routinely...

Read


Clinical Lab 2.0: Data Driven Strategies that Position Labs to Compete in the Changing Healthcare Landscape

Summary: Clinical Lab 2.0 facilitates thought leadership efforts to identify opportunities and threats that provide insight into laboratory operations and identify value streams to drive efficiency for the laboratory, health systems and positive outcomes for patients.Clinical Lab 2.0 is all about the future of capturing new customers, partners and markets.  For laboratories to compete, new...

Read